Portable and versatile Point-of-care diagnostics
Two-stage EU funding for the development of highly sensitive, selective, and user-friendly point-of-care diagnostic solutions according to REASSURED criteria. Submission for Phase 1 by 13.04.2027, Phase 2 by 22.09.2027.
Discover your potential with AI support
- Find out if this grant matches your project
- Develop your application together with AI
- Get matched with many more suitable grants
Grant criteria
Funding objective
Support for the optimization, validation, and clinical trials of novel point-of-care diagnostic devices that improve sensitivity, specificity, environmental sustainability, and user-friendliness, and are particularly suitable for resource-limited settings. The measures include comparative performance studies, conformity assessment according to IVDR/MDR, and value-based health technology assessment.
Eligible expenses
- Personnel expenses
- Material costs
- Subcontractor services
Eligible to apply
- Companies
- Educational Institutions
- Non-profit Organizations
Funding requirements
- Application by a consortium of independent legal entities from EU or associated countries
- Two-stage submission procedure (blind First Stage)
Documents required for application
- Cover letter
- Project description
- Financial plan
- Curriculum vitae
Evaluation criteria
- Innovative content of the project
- Impact on patient outcomes
- Quality of implementation and consortium
Description
The two-stage EU funding initiative “Portable and Versatile Point-of-Care Diagnostics” supports companies, research institutions, and non-profit organizations in Europe in developing highly sensitive and user-friendly diagnostic devices according to the REASSURED criteria. In Phase 1 (submission deadline 13.04.2027), a blind selection process takes place; in Phase 2 (until 22.09.2027), a full application must be submitted. The total budget per project ranges between €5 million and €7 million, with a maximum funding rate of 70%. Eligible costs include personnel expenses, material costs, and subcontractor services, with a particular focus on SMEs. Applicant consortia must consist of independent legal entities from different EU or associated countries and must submit, alongside a cover letter and project description, a financial plan and CVs as part of the application package.
The focus is on the optimization, validation, and clinical evaluation of novel point-of-care diagnostic devices that offer high sensitivity, specificity, environmental and user-friendliness for resource-limited settings. Comparative performance studies, conformity assessments according to IVDR/MDR, and value-based Health Technology Assessment analyses are required. The results should enable healthcare professionals and patients in acute and primary care to achieve faster and more precise diagnoses, thereby accelerating therapy decisions and improving disease management. Through structured collaboration within the consortium, excellence, impact, and feasibility will be comprehensively assessed. Interested applicants are encouraged to review the funding guidelines and upload their proposals on time to the Horizon Europe portal.